Se. Jones et al., Differences in the effects of urinary incontinence agents S-oxybutynin andterodiline on cardiac K+ currents and action potentials, BR J PHARM, 131(2), 2000, pp. 245-254
1 The cardiac electrophysiological effects of S-oxybutynin, a single-enanti
omer drug under evaluation for the management of urinary incontinence, have
been investigated and compared with those of terodiline, an incontinence a
gent withdrawn following reports of QT lengthening and ventricular tachyarr
hythmia. Membrane currents were recorded from whole-cell configured guineap
ig and rabbit ventricular myocytes, and action potentials were recorded fro
m guinea-pig and rabbit papillary muscles.
2 L-type Ca2+ current (I-Ca,I-L), rapidly-activating K+ current (I-Kr) and
slowly-activating K+ current (I-Ks) were unaffected by submicromolar S-oxyb
utynin and inhibited by higher concentrations; IC50 values were 17.8 mu M f
or I-Ca,L, 12 mu M for I-Kr, and 41 mu M for I-Ks. Terodiline IC50 values w
ere somewhat lower for I-Ca,I-L (15.2 mu M) and I-Ks (30 mu M), but 24 fold
lower in the case of I-Kr (0.5 mu M).
3 The durations of action potentials in guinea-pig and rabbit papillary mus
cles driven at 1 Hz were unaffected or moderately shortened by 0.1-100 mu M
S-oxybutynin, but lengthened by terodiline. Terodiline (less than or equal
to 10 mu M) also depressed maximal upstroke velocity.
4 The action potential plateau shortened by an average of 23% when control
rabbit papillary muscles were driven at 0.4 Hz instead of 1 Hz. Plateau sho
rtening was significantly smaller in the presence of drugs (30 mu M S-oxybu
tynin, 3 and 30 mu M terodiline), suggesting that they suppress the transie
nt outward current (I-to) involved in rate-dependent shortening. In experim
ents on rabbit ventricular myocytes, 3 and 30 mu M S-oxybutynin inhibited I
-to by 9+/-2% and 35+3%, respectively, whereas 3 and 30 mu M terodiline inh
ibited the current by 31+/-3% and 87+/-3%, respectively.
5 The results indicate that S-oxybutynin has relatively weak non-specific e
ffects on cardiac ion channels, and that clinically relevant submicromolar
concentrations are unlikely to have terodiline-like proarrhythmic actions o
n the myocardium.